Aluminum granuloma after administration of the quadrivalent human papillomavirus vaccine. report of a case

American Journal of Dermatopathology

Volumn 30, Issue 6, 2008, Pages 622-624

  Marsee, Derek K ^a   Williams, John M ^a   Velazquez, Elsa F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aluminum; Granuloma; HPV; Vaccine

Indexed keywords

ALUMINUM; AMMONIA; AURINTRICARBOXYLIC ACID; WART VIRUS VACCINE; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ADULT; ALUMINUM GRANULOMA; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GRANULOMA ANNULARE; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOID CELL; PERIODIC ACID SCHIFF STAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATOID NODULE; SKIN FIBROSIS; SKIN NECROSIS; TREATMENT RESPONSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; GRANULOMA; SKIN DISEASE;

ADJUVANTS, PHARMACEUTIC; ADULT; ALUMINUM; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRANULOMA; HUMANS; PAPILLOMAVIRUS VACCINES; SKIN DISEASES;

EID: 59849106008     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318185a691     Document Type: Article

References (12)

1. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1-24.
2. Chong H, Brady K, Metze D, et al. Persistent nodules at injection sites (aluminium granuloma)-clinicopathological study of 14 cases with a diverse range of histological reaction patterns. Histopathology. 2006; 48:182-188.
3. Miliauskas JR, Mukherjee T, Dixon B. Postimmunization (vaccination) injection-site reactions. A report of four cases and review of the literature. Am J Surg Pathol. 1993;17:516-524.
4. Valtulini S, Macchi C, Ballanti P, et al. Aluminium hydroxide-induced granulomas in pigs. Vaccine. 2005;23:3999-4004.
5. Ohtsuki Y, Yamaguchi T, Sonobe H, et al. A simplified aluminum stain in paraffin sections of bone from hemodialysis patients. Stain Technol. 1989; 64:55-59.
6. Del Giudice G, Podda A, Rappuoli R. What are the limits of adjuvanticity? Vaccine. 2001;20 (Suppl 1):S38-S41.
7. Garcia-Patos V, Pujol RM, Alomar A, et al. Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts. Arch Dermatol. 1995;131:1421-1424.
8. Fairweather P, O'Rourke T, Strutton G. Rare complication of Q fever vaccination. Australas J Dermatol. 2005;46:124-125.
9. Harro CD, Pang YY, Roden RB, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst. 2001;93:284-292.
10. McFadden N, Lyberg T, Hensten-Pettersen A. Aluminum-induced granulomas in a tattoo. J Am Acad Dermatol. 1989;20:903-908.
11. Elston DM, Bergfeld WF, McMahon JT. Aluminum tattoo: a phenomenon that can resemble parasitized histiocytes. J Cutan Pathol. 1993;20: 326-329.
12. Gherardi RK, Coquet M, Cherin P, et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain. 2001;124:1821-1831.